New fixed-dose once-a-day starting regimens: interview with Cal Cohen, M.D. Interview by John S. James.
A leading AIDS physician looks at the advantages and disadvantages of once-a day treatment with two new fixed-dose combinations of previously approved drugs, for patients who are first starting antiretrovirals.
Cohen
Cal
C
D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors